Safe and Explainable AI

Clinical trial NCT06694181 · RECRUITING

Trial details

NCT number: NCT06694181
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Study type: OBSERVATIONAL

Artifical Inteligence Cardiology Breast Cancer Sepsis

Start date: 2025-11-29
Primary completion: 2028-11-01
Enrollment: 300000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.